Tucson cancer-drug firm eyes IPO to raise $29 million

A Tucson-based cancer drug company is looking to raise $29 million in an initial public offering of stock, and continues to raise private funding and form key partnerships.

Cancer Prevention Pharmaceuticals Inc. — whose leading drug candidate is based on technology developed partly at the University of Arizona — is waiting for the U.S. Securities and Exchange Commission to declare its stock registration statement effective, after which it will be priced and issued.

Click here for full article